Andrew Witty

Sir Andrew Witty was named chief executive officer, UnitedHealth Group in February 2021, in addition to his role as chief executive officer of Optum. As UnitedHealth Group CEO, Sir Andrew is responsible for the strategic direction and overall performance of the enterprise and its long-term growth agenda. He is also a member of the UnitedHealth Group board of directors and the Chief Executive Office. Witty was named executive vice president, UnitedHealth Group, and chief executive office of Optum, in March 2018. He was also a member of the Office of the Chief Executive and previously served as a UnitedHealth Group company director. From 2008 to 2017, Witty was chief executive officer and a director of the leading pharmaceutical manufacturer GlaxoSmithKline plc (GSK). He joined GSK in 1985, and prior to being named CEO, served as president of GSK Europe. Witty is former chancellor of the University of Nottingham, a British public research university, and served on the Singapore Prime Minister’s Research, Innovation and Enterprise Council. He is an advisor to 8VC and the Bill and Melinda Gates Foundation. In November 2020, Witty became Chair of the Imperial College Business School Advisory Board. Witty was knighted in 2012 for services to the U.K. economy. In 2017, he was named an Honorary Citizen by Singapore for his contributions to the country’s growth and development. From April to November 2020, Witty took a leave of absence from his positions at UnitedHealth Group and Optum to serve as a Global Envoy for the World Health Organization’s COVID-19 efforts. He also served as an Advisor to the U.K. Government COVID Vaccine Taskforce.